Pharmacology Corner

Pharmacology education for healthcare professionals

  • Animations
  • Psychopharmacology
  • PowerPoints
  • About
Menu
  • Animations
  • Psychopharmacology
  • PowerPoints
  • About

Tag: sutent

NICE recommends sunitinib (Sutent) for the first-line treatment of metastatic renal cancer

NICE (UK) recommends the tyrosine kinase inhibitor sunitinib (Sutent) first line treatment of metastatic renal cell carcinoma. Implications for patients that are on immunotherapy

Pharmacology Corner

Pharmacology education for healthcare professionals

All rights reserved

Are you a visual learner interested in learning psychopharmacology? Click here to get our videos